RADPOS is an accurate and precise QA tool for dose and position measurements for CyberKnife deliveries with respiratory motion compensation.
Purpose: The CyberKnife robotic radiosurgery system uses Synchrony respiratory motion compensation, which requires independent performance verification. In this work, the RADPOS 4D dosimetry system's motion measurements are compared with internal fiducial position measurements. In addition, RADPOS measurements are compared with Synchrony's predictive correlation model, which is based on internal fiducial and external LED marker position measurements. Methods: A treatment plan was created for a lung insert containing fiducials, RADPOS detector, and Solid Water tumor phantom. Two Quasar Respiratory Motion Phantoms (Q1 and Q2) and two RADPOS detectors (R1 and R2) were used: Q1 simulated lung motion with a lung insert moving in the superior/inferior direction, while Q2 simulated chest motion with a chest platform moving in the anterior/posterior direction. Before treatment, R1 was secured inside of the tumor phantom within Q1, while LED markers and R2 were positioned on the chest platform of Q2. Two treatment delivery cases were studied: isocentric plan (I) and non‐isocentric patient plan (P). Four motion cases were studied: no motion (0), sinusoidal and in‐phase (1), sinusoidal and out‐of‐phase (2), patient waveform and out‐of‐phase (3). A coordinate alignment algorithm was implemented, allowing RADPOS and model position data to be compared within the fiducial coordinate system. Results: The standard deviation of the differences between RADPOS and fiducial position measurements was below 0.6 mm for all experimental cases. The standard deviation of the differences between RADPOS and model position data was 1.0, 1.5, and 1.6 mm along the primary direction of motion for case I1, I2, and P3, respectively. Conclusion: Our work demonstrates that RADPOS is a useful tool for independent quality assurance of CyberKnife treatment with Synchrony respiratory compensation. RADPOS and fiducial position measurement closely match, and RADPOS confirms the effectiveness of CyberKnife's Synchrony motion tracking. This work was supported by OCAIRO (Ontario Consortium for Adaptive Interventions in Radiation Oncology) grant.
Introduction: RADPOS 4D dosimetry system consists of a microMOSFET dosimeter combined with an electromagnetic positioning sensor, which allows for performing real‐time dose and position measurements simultaneously. In this report the use of RADPOS as an independent quality assurance (QA) tool during CyberKnife 4D radiotherapy treatment is described. In addition to RADPOS, GAFCHROMIC® films were used for simultaneous dose measurement. Methods: RADPOS and films were calibrated in a Solid Water® phantom at 1.5 cm depth, SAD= 80 cm, using 60 mm cone. CT based treatment plan was created for a Solid Water® breast phantom containing metal fiducials and RADPOS probe. Dose calculations were performed using iPlan pencil beam algorithm. Before the treatment delivery, GAFCHROMIC® film was inserted inside the breast phantom, next to the RADPOS probe. Then the phantom was positioned on the chest platform of the QUASAR, to which Synchrony LED optical markers were also attached. Position logging began for RADPOS and the Synchrony tracking system, the QUASAR motion was initiated and the treatment was delivered. Results: RADPOS position measurements very closely matched the LED marker positions recorded by the Synchrony camera tracking system. The RADPOS measured dose was 2.5% higher than the average film measured dose, which is within the experimental uncertainties. Treatment plan calculated dose was 4.1 and 1.6% lower than measured by RADPOS and film, respectively. This is most likely due to the inferior nature of the dose calculation algorithm. Conclusions: Our study demonstrates that RADPOS system is a useful tool for independent QA of CyberKnife treatments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.